Therapy News and Research

RSS

MicroBiome Therapeutics' NM 505 drug can improve tolerability of metformin

MicroBiome TherapeuticsTM LLC, today reported positive topline results from a proof of concept study testing whether its investigational drug, NM 505, can improve the tolerability of metformin, the first-line therapy for Type 2 diabetes worldwide.

26 Sep 2014

International organizations join forces to develop inhaled form of oxytocin for postpartum hemorrhage

An international group of public and private organizations is collaborating to accelerate development of an innovative heat-stable and low-cost inhaled form of oxytocin to manage postpartum hemorrhage in resource-poor settings.

26 Sep 2014

Anti-inflammatory treatment may prevent heterotopic ossification

An anti-inflammatory treatment, studied in the labs of regenerative medicine specialists and trauma surgeons, may prevent what's become one of the war-defining injuries for today's troops.

26 Sep 2014

Lya Segall Ovarian Cancer Institute at Mercy opens in Maryland

Mercy Medical Center has announced the opening of The Lya Segall Ovarian Cancer Institute at Mercy, the first center in Maryland specifically designed and dedicated solely for the diagnosis and treatment of ovarian cancer.

26 Sep 2014

Sumitomo Dainippon Pharma, SanBio to jointly develop SB623 in the U.S. and Canada

Sumitomo Dainippon Pharma Co., Ltd. and SanBio Co., Ltd., acting through its U.S. subsidiary SanBio, Inc., announced on September 26 that the two companies have entered into a joint development and license agreement for exclusive marketing rights in the U.S. and Canada ("Agreement") for SB623, a cell therapy for the treatment of patients with chronic stroke discovered and currently under development by SanBio.

26 Sep 2014

Thirteen research projects to explore nondrug approaches to manage pain, other health conditions

Thirteen research projects totaling approximately $21.7 million over 5 years will explore nondrug approaches to managing pain and related health conditions such as post-traumatic stress disorder (PTSD), drug abuse, and sleep issues. The effort seeks to enhance options for the management of pain and associated problems in U.S. military personnel, veterans, and their families.

26 Sep 2014

Colorado cancer researchers launch feasibility study to build nation's first carbon-ion radiotherapy facility

Colorado cancer researchers and medical doctors on Wednesday announced they are launching a $200,000 feasibility study as a key step to building the nation's first carbon-ion radiotherapy research and treatment facility in Aurora, where they and colleagues hope to investigate and provide to patients leading-edge radiation therapy that is effective against the deadliest cancers and now is available only in Europe and Japan.

25 Sep 2014

NCCN ORP awards four research grants to advance development of nintedanib

The National Comprehensive Cancer Network Oncology Research Program has awarded four grants to investigators to evaluate and define the clinical effectiveness of the investigational compound nintedanib (BIBF 1120) in non-small cell lung, colorectal, and gastrointestinal cancers.

25 Sep 2014

Innovative partnership provides effective intervention program for substance-exposed babies, toddlers

Two decades after its initiation, the University of Miami Linda Ray Intervention Program for substance-exposed babies and toddlers demonstrates long-term success.

25 Sep 2014

New NIH program awards $2.5 million to spur innovation in mobile health

A new NIH program is awarding nearly $2.5 million to spur innovation in mobile communication technologies and software applications used in biomedical research in low- and middle-income countries (LMICs).

25 Sep 2014

Study identifies potential way to improve treatment for chemo-resistant ovarian cancer

Ovarian cancer is the most deadly gynecological cancer, claiming the lives of more than 50% of women who are diagnosed with the disease.

25 Sep 2014

Bacterial communication molecules can be manipulated to prevent cancer cells from spreading

Cancer, while always dangerous, truly becomes life-threatening when cancer cells begin to spread to different areas throughout the body.

25 Sep 2014

Northwestern scientists develop first animal model for ALS dementia

The first animal model for ALS dementia, a form of ALS that also damages the brain, has been developed by Northwestern Medicine- scientists. The advance will allow researchers to directly see the brains of living mice, under anesthesia, at the microscopic level. This will allow direct monitoring of test drugs to determine if they work.

25 Sep 2014

ECT benefits demonstrated in randomised controlled trial

Electroconvulsive therapy is more effective than pharmacological treatment for the reduction of depressive symptoms in patients with treatment-resistant bipolar depression, Norwegian study data show.

24 Sep 2014

Chemotherapy may benefit advanced pulmonary carcinoid tumour patients

A review of patients with advanced pulmonary carcinoid tumours shows that they can be responsive to chemotherapy.

24 Sep 2014

Antacids linked to reduced erlotinib efficacy

Acid suppression therapy may negatively impact outcome among patients receiving erlotinib for advanced non-small-cell lung cancer, Canadian study findings show.

24 Sep 2014

Novel treatment makes life-saving difference to young patients with Ph-like ALL

St. Jude Children's Research Hospital investigators found that adjusting treatment based on early response to chemotherapy made a life-saving difference to young patients with an acute lymphoblastic leukemia (ALL) subtype associated with a poor outcome.

24 Sep 2014

West Virginia home health community takes part in Save Home Health rally

Representatives of the West Virginia home health community – including Parkersburg area clinicians, family members and advocates as well as national leaders – today took part in a Save Home Health rally to commend special guest Congressman David McKinley (WV-1) and speak out against unprecedented Medicare cuts of 14 percent to home health services that went into effect on January 1 as part of the Affordable Care Act (ACA).

24 Sep 2014

Physical therapist in Southern California launches new book, Rehab the Mind

The highest rated physical therapist in Southern California, Dr. Justin C. Lin, is pleased to announce the launch of his new book, Rehab the Mind, Revive the Body, (known hereafter as the "Book" or "RR"), an inspirational account of the power of active healing based on real life stories of his patients.

24 Sep 2014

ImmunoCellular signs licensing agreement with Caltech to develop antigen-specific T-cell technology

ImmunoCellular Therapeutics, Ltd. announced today that it has established a licensing agreement with the California Institute of Technology for exclusive rights to novel technology for the development of certain antigen specific T-cell immunotherapies for the treatment of cancer.

24 Sep 2014

Therapy News and Research

MicroBiome Therapeutics' NM 505 drug can improve tolerability of metformin

International organizations join forces to develop inhaled form of oxytocin for postpartum hemorrhage

Anti-inflammatory treatment may prevent heterotopic ossification

Lya Segall Ovarian Cancer Institute at Mercy opens in Maryland

Sumitomo Dainippon Pharma, SanBio to jointly develop SB623 in the U.S. and Canada

Thirteen research projects to explore nondrug approaches to manage pain, other health conditions

Colorado cancer researchers launch feasibility study to build nation's first carbon-ion radiotherapy facility

NCCN ORP awards four research grants to advance development of nintedanib

Innovative partnership provides effective intervention program for substance-exposed babies, toddlers

New NIH program awards $2.5 million to spur innovation in mobile health

Study identifies potential way to improve treatment for chemo-resistant ovarian cancer

Bacterial communication molecules can be manipulated to prevent cancer cells from spreading

Northwestern scientists develop first animal model for ALS dementia

ECT benefits demonstrated in randomised controlled trial

Chemotherapy may benefit advanced pulmonary carcinoid tumour patients

Antacids linked to reduced erlotinib efficacy

Novel treatment makes life-saving difference to young patients with Ph-like ALL

West Virginia home health community takes part in Save Home Health rally

Physical therapist in Southern California launches new book, Rehab the Mind

ImmunoCellular signs licensing agreement with Caltech to develop antigen-specific T-cell technology

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News